The largest database of trusted experimental protocols

Ho 1 sirna

Manufactured by Qiagen
Sourced in Italy

The HO-1 siRNA is a laboratory tool designed to facilitate the study of heme oxygenase-1 (HO-1) gene expression. It functions by targeting and silencing the HO-1 gene, allowing researchers to investigate the biological role and function of this important enzyme.

Automatically generated - may contain errors

2 protocols using ho 1 sirna

1

HO-1 Silencing and SP/LPS Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with HO-1 siRNA, and Non-Correlated (NC) siRNA (Qiagen, Milan, Italy) as previously reported [25 (link)] In brief, cells (2 X 105) were seeded onto 60-mm dishes in medium without antibiotics; 24 h later, the transfection of siRNAs was carried out with Lipofectamine RNAiMAX (Invitrogen). All transfections were carried out with 20 μM duplex siRNA in medium without FBS and antibiotics. After 24 h, cells were split into 6-well plates to perform further analysis. After 24 h (48 h after transfection), cells were untreated or treated for 24 hours with SP and/or LPS and mRNA analysis were performed by RT-qPCR. Experiments were repeated two times.
+ Open protocol
+ Expand
2

Targeted Overexpression and Knockdown of HO-1 in HMEC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HMEC cells were plated in antibiotic free media in a 6-well plate at 1 × 105 cells/well a day before transfection. Cells were transfected with Lipofectamine™ 2000 in Opti-MEM I Reduced Serum Medium. Each well was transfected for 5 hr with 4.0 μg of either HO-1 expression plasmid (pcDNA 3.1D/V5-HO-1) or the empty vector (pcDNA 3.1D/V5-His/lacZ) for the targeted over expression of HO-1. The HO-1 expression plasmid was generated by cloning HO-1 cDNA into Hind III and Pme I sites of pcDNA 3.1D/V5-His/lacZ vector (Invitrogen). The HO-1 expressing cassette was released from the vector via restriction digestion and gel-purified. Transfection efficiency was determined using the Genlantis X-Gal Staining™ kit (San Diego, CA) according to the manufacturer's instructions. The percentage of cells with blue stain was examined under the microscope and more than 50% efficiency was obtained (supplementary figure 1). The targeted knockdown of HO-1 was achieved by transfecting cells for 5 hr with HO-1 siRNA (Qiagen, Valencia, CA) at a final concentration of 40 nM. A non-targeting siRNA Scrambled was used as control (Qiagen, Valencia, CA). The over expression and knockdown of the HO-1 gene was assessed by qPCR and Western blot analysis at 3 days after transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!